Cargando…

Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation

Methotrexate (MTX) is a widely used neurotoxic drug with broad antineoplastic and immunosuppressant spectra. However, the exact molecular mechanisms by which MTX inhibits hippocampal neurogenesis are yet unclear. Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, has recently shown neuroprote...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Mohamed, Eldemerdash, Omar Mohsen, Elshaffei, Ismail Mohamed, Yousef, Einas Mohamed, Senousy, Mahmoud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821704/
https://www.ncbi.nlm.nih.gov/pubmed/36614208
http://dx.doi.org/10.3390/ijms24010766
_version_ 1784865762446409728
author Taha, Mohamed
Eldemerdash, Omar Mohsen
Elshaffei, Ismail Mohamed
Yousef, Einas Mohamed
Senousy, Mahmoud A.
author_facet Taha, Mohamed
Eldemerdash, Omar Mohsen
Elshaffei, Ismail Mohamed
Yousef, Einas Mohamed
Senousy, Mahmoud A.
author_sort Taha, Mohamed
collection PubMed
description Methotrexate (MTX) is a widely used neurotoxic drug with broad antineoplastic and immunosuppressant spectra. However, the exact molecular mechanisms by which MTX inhibits hippocampal neurogenesis are yet unclear. Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, has recently shown neuroprotective effects; however, its full mechanism is unexplored. This study investigated the potential of Dex to mitigate MTX-induced neurotoxicity and memory impairment in rats and the possible role of the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway. Notably, no former studies have linked this pathway to MTX-induced neurotoxicity. Male Sprague Dawley rats were placed into four groups. Group 1 received saline i.p. daily and i.v. on days 8 and 15. Group 2 received Dex at 10 μg/kg/day i.p. for 30 days. Group 3 received MTX at 75 mg/kg i.v. on days 8 and 15, followed by four i.p. doses of leucovorin at 6 mg/kg after 18 h and 3 mg/kg after 26, 42, and 50 h. Group 4 received MTX and leucovorin as in group 3 and Dex daily dosages as in group 2. Bioinformatic analysis identified the association of miR-15a with ROCK-1/ERK1/2/CREB/BDNF and neurogenesis. MTX lowered hippocampal doublecortin and Ki-67, two markers of neurogenesis. This was associated with the downregulation of miR-15a, upregulation of its target ROCK-1, and reduction in the downstream ERK1/2/CREB/BDNF pathway, along with disturbed hippocampal redox state. Novel object recognition and Morris water maze tests demonstrated the MTX-induced memory deficiencies. Dex co-treatment reversed the MTX-induced behavioral, biochemical, and histological alterations in the rats. These neuroprotective actions could be partly mediated through modulating the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway, which enhances hippocampal neurogenesis.
format Online
Article
Text
id pubmed-9821704
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98217042023-01-07 Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation Taha, Mohamed Eldemerdash, Omar Mohsen Elshaffei, Ismail Mohamed Yousef, Einas Mohamed Senousy, Mahmoud A. Int J Mol Sci Article Methotrexate (MTX) is a widely used neurotoxic drug with broad antineoplastic and immunosuppressant spectra. However, the exact molecular mechanisms by which MTX inhibits hippocampal neurogenesis are yet unclear. Dexmedetomidine (Dex), an α2-adrenergic receptor agonist, has recently shown neuroprotective effects; however, its full mechanism is unexplored. This study investigated the potential of Dex to mitigate MTX-induced neurotoxicity and memory impairment in rats and the possible role of the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway. Notably, no former studies have linked this pathway to MTX-induced neurotoxicity. Male Sprague Dawley rats were placed into four groups. Group 1 received saline i.p. daily and i.v. on days 8 and 15. Group 2 received Dex at 10 μg/kg/day i.p. for 30 days. Group 3 received MTX at 75 mg/kg i.v. on days 8 and 15, followed by four i.p. doses of leucovorin at 6 mg/kg after 18 h and 3 mg/kg after 26, 42, and 50 h. Group 4 received MTX and leucovorin as in group 3 and Dex daily dosages as in group 2. Bioinformatic analysis identified the association of miR-15a with ROCK-1/ERK1/2/CREB/BDNF and neurogenesis. MTX lowered hippocampal doublecortin and Ki-67, two markers of neurogenesis. This was associated with the downregulation of miR-15a, upregulation of its target ROCK-1, and reduction in the downstream ERK1/2/CREB/BDNF pathway, along with disturbed hippocampal redox state. Novel object recognition and Morris water maze tests demonstrated the MTX-induced memory deficiencies. Dex co-treatment reversed the MTX-induced behavioral, biochemical, and histological alterations in the rats. These neuroprotective actions could be partly mediated through modulating the miR-15a/ROCK-1/ERK1/2/CREB/BDNF pathway, which enhances hippocampal neurogenesis. MDPI 2023-01-01 /pmc/articles/PMC9821704/ /pubmed/36614208 http://dx.doi.org/10.3390/ijms24010766 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Taha, Mohamed
Eldemerdash, Omar Mohsen
Elshaffei, Ismail Mohamed
Yousef, Einas Mohamed
Senousy, Mahmoud A.
Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
title Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
title_full Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
title_fullStr Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
title_full_unstemmed Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
title_short Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
title_sort dexmedetomidine attenuates methotrexate-induced neurotoxicity and memory deficits in rats through improving hippocampal neurogenesis: the role of mir-15a/rock-1/erk1/2/creb/bdnf pathway modulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821704/
https://www.ncbi.nlm.nih.gov/pubmed/36614208
http://dx.doi.org/10.3390/ijms24010766
work_keys_str_mv AT tahamohamed dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation
AT eldemerdashomarmohsen dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation
AT elshaffeiismailmohamed dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation
AT yousefeinasmohamed dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation
AT senousymahmouda dexmedetomidineattenuatesmethotrexateinducedneurotoxicityandmemorydeficitsinratsthroughimprovinghippocampalneurogenesistheroleofmir15arock1erk12crebbdnfpathwaymodulation